CompoAtlas

COMPLEXE DE ACIDE FOLIQUE

Food supplement declared in France, declaration No 2020-4-625, decision dated 16 April 2020

COMPLEXE DE ACIDE FOLIQUE is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). 1 rule of use applies to its ingredients (limits and warnings).

Brand
not provided
Food business operator placing the product on the market
SCHIHA VITAL GMBH
Status
Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
Form
Capsule
Daily dose
1 capsule
Directions for use
Prendre 1 capsule par jour avec assez de liquide.
Not recommended for (according to the manufacturer)
Femmes allaitantes

Declaration 301421, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Plants

PlantPartPreparationPer day
Murraya koenigii (L.) Spreng.FeuilleExtrait sec aqueux155.56 mg
Rosa canina L.FruitExtrait sec aqueux53.33 mg
Vitex agnus-castus L.FruitExtrait sec aqueux41.66 mg

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
Acide ptéroylmonoglutamiqueFolates (vitamine B9)1,000 µg200 µg
MéthylcobalamineVitamine B12pas d'effet indésirable définidose annulée par le Conseil d'État en 2011
CholécalciférolVitamine D100 µg (4,000 UI)5 µg (200 UI)
Bisglycinate de zincZinc25 mg15 mg

Additives

E464

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

List recorded in 2020. Photograph the packaging to check whether it has changed. Photograph the packaging

Label warnings

Son utilisation est déconseillée chez les femmes antécédents personnels ou familiaux de cancer du sein et les femmes allaitantes. En cas d’effets secondaires, cesser l‘utilisation et consulter un médecin.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Other declarations with the same name

In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.

List recorded in 2020. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line